A Phase 2, Randomized, Double-Blind, Placebo- Controlled Study of Chemo-Immunotherapy Combination using Motolimod with Pegylated Liposomal Doxorubicin in Recurrent Or Persistent Ovarian Cancer: A Gynecologic Oncology Group Partners Study
No Thumbnail Available
Authors
Monk, B. J.
Brady, M. F.
Aghajanian, C.
Lankes, H. A.
Rizack, T.
Leach, J.
Fowler, J. M.
Higgins, R.
Hanjani, P.
Morgan, M.
Issue Date
2017
Type
Journal Article
Language
Keywords
Alternative Title
Abstract
Description
Citation
Monk, B. J.; Brady, M. F.; Aghajanian, C.; Lankes, H. A.; Rizack, T.; Leach, J., et al. (2017). A Phase 2, Randomized, Double-Blind, Placebo- Controlled Study of Chemo-Immunotherapy Combination using Motolimod with Pegylated Liposomal Doxorubicin in Recurrent Or Persistent Ovarian Cancer: A Gynecologic Oncology Group Partners Study. Ann Oncol, May 1 2017, 28(5):996-1004. doi: http://dx.doi.org/10.1093/annonc/mdx049
Publisher
License
Journal
Volume
Issue
PubMed ID
DOI
ISSN
1569-8041
0923-7534
0923-7534